Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

BBOTBBOT
4 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in BRIDGEBIO ONCOLOGY THERAPEUT

WELLINGTON MANAGEMENT GROUP LLP holds 2.8M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $21.3M as of 2026-Q2. The position was decreased (-1.0% shares). BBOT represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$21.3M

Current Shares

2.8M

Total Value Change

-$13M

Total Shares Change

-171,961

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.8M
-1.0%
$21.3M0.0%$7.62
0
2026-Q1
Decreased
2.8M
-3.0%
$25.2M0.0%$9.74
0
2025-Q4
Decreased
2.9M
-1.8%
$36.4M0.0%$12.37
0
2025-Q3
New
3M
-
$34.3M0.0%$11.47
40

Other major holders of BBOT: Alphabet Inc., CITADEL ADVISORS LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used